Biotyx Medical (Shenzhen) Co., Ltd. was founded in 2019 as a subsidiary from LifeTech Scientific Corporation (01302.HK), specializing in the research and development of iron-based bioresorbable materials and devices. Biotyx Medical is the only company in the world that develops iron-based bioresorbable vascular stents. Clinical implants have been carried out in the United States, Europe, Southeast Asia and China; three products have passed the special approval procedure for innovative medical devices of the National Medical Products Administration (NMPA) and entered the "green channel". Sales licenses in the United States and Malaysia in 2021, and the CE certificate in 2023. Adhering to the mission of providing safe and innovative cardiovascular medical devices to doctors and patients around the world, Biotyx is committed to becoming a global leader in the cardiovascular field.
